Clinical Trials Service
Clinical Trials Service
Contact Us: Division of
Allergy and Immunology Ph.
402.280.5975 |
The Center is conducting the following new and exciting studies. If you or someone you know is eligible and interested, we would love to hear from you. Please call (402) 280-5975.
Patient Demographics The Omaha area has a population of over 750,000. The Division’s clinical research patient database alone is currently comprised of over 5,000 patients and is constantly growing through the various recruitment efforts including media advertising, health fair involvement as well as volunteer work. Our diverse patient population is drawn not only from the Omaha metropolitan area (urban/suburban), but also from the surrounding communities in Eastern Nebraska and Western Iowa (rural). Areas of Research Acute and chronic otitis media Acute and chronic urticaria Acute sinusitis Allergic asthma Allergic bronchopulmonary aspergillosis Allergic conjunctivitis Angioedema Asthma in pregnancy B cell immunodeficiencies Bronchitis Common variable immunodeficiency Contact dermatitis Drug allergy Exercise induced asthma Food allergy and food hypersensitivity Immunizations and immunoprophylaxis Insect allergy Latex allergy Management of immunotherapy Non-allergic asthma Nasal polyposis Perennial allergic rhinitis Seasonal allergic rhinitis Status asthmaticus T-cell immunodeficiencies Vasomotor rhinitis Urticaria
Procedures and Equipment Available
Acoustic Rhinometry Aeroallergen challenge Exercise challenge Hypertonic Saline challenge Methacholine challenge Bronchoprovocation Challenges Biomarker Assays (Interleukins/Cytokines, Leukotrienes, Histamine, Tryptase, ECP) Digital Electrocardiography Machine Full Pulmonary Function Laboratory Immediate and Delayed Hypersensitivity Skin Testing Immunotherapy Inpatient Beds Nasal Allergen Challenges and Lavage Nitric Oxide Measurements (oral/nasal) Oral Desensitization Parenteral Therapy Facilities Phlebotomy Pollen Collection Radiology Suite for Routine X-Rays, MRIs ,CTs, Nuclear Studies Remote Data Entry Capabilities Spirometry Sputum Induction Treadmill Exercise Testing
Investigators
Thomas B. Casale, M.D.
Robert G. Townley, M.D. Jeffrey R. Stokes, M.D. Associate Professor of Medicine, Fellowship Program Director, Fellowship Program Bio
Russell J. Hopp, D.O.
Staff Patrick De Nier: Operations Manager Tony Tony Romero, MS: Budget, Contracts, & Regulatory Documents Dian Jean Kessler, RN, BSN, CCRC: Research Coordinator Lori Lori Mahon, RN, BSN,CCRC: Research Coordinator Jani Janie Misfieldt, MA, CCRC: Research Coordinator Jean Jean Casale, CMA: Research Coordinator
Current Clinical Trials
▪ Non-Invasive Ways to Evaluate Lung Disease After Treatment with Xolair Condition: Use of medium-high dose corticosteroids, Moderate- Severe Asthma Age: > 12
▪ Exhaled Breath Condensate and Nitric Oxide: Non-Invasive Evaluation of Lung Disease after Treatment with Xolair Condition: Allergic Asthma Age: > 12 years
▪ 26 Week Treatment Assessing the Safety of Indacaterol in Patients with Moderate to Severe Asthma Currently Not Enrolling Subjects Conditions: Moderate-Severe Asthma Age: >12 years
▪ Effect of Montelukast in Subjects with Allergic Rhinitis or Allergic Asthma Conditions: Allergic Asthma or Allergic Rhinitis Age: >12 years
▪ Safety, Tolerability, Efficacy of Intravenous Doses of QAZ576 in Moderate Persistent Allergic Asthma Condition: Moderate Persistent Allergic Asthma Age: 19-55 years
▪ Effects of an H3 Receptor Antagonist on Congestion Following Nasal Allergen Challenge in Subject with Seasonal Allergic Rhinitis Condition: Seasonal Allergic Rhinitis Age: 19-55 years
▪ Safety and Efficacy of Olopaladine HCL Nasal Spray in Subjects with Seasonal Allergic Rhinitis Condition: Seasonal Allergic Rhinitis Age: 6-11 years
▪ Trial in Adults for the Sublingual-Oral Immunotherapy (SLIT) of Allergic Rhinoconjunctivitis With or Without Asthma Caused by Ragweed Pollen. Condition: Ragweed Allergies Age: 18-50 years
▪ A Study to Test the Safety and Bronchodilatory Effect of MK-0476 in Patients with Chronic Asthma Condition: Mild-Moderate Asthma Age: 15-65 years
▪ A Study to Evaluate The Safety and Effect On Exercise Challenge Testing of Multiple Fixed Subcutanteous Doses of a Humanized Ant-Interleukin-9 Monoclonal Antibody in Adults with Stable Asthma and Exercise-Induced Bronchoconstriction Condition: Exercise Induced Asthma Age: 19-50
▪ A Study to Evaluate the Efficacy and Safety of Nasal Carbon Dioxide in the Treatment of Seasonal Allergic Rhinitis Condition: Ragweed Allergies Age: 18-65 years |
Home
| Team Members
|
Patient Information |
Current Clinical Trials |
Fellowship Program
